Cervical Screening Systems in Eastern Europe and Central Asia: A Comparative Policy Evaluation.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Evolving Clinicopathological Characteristics of Women with Locally Advanced Cervical Cancer Treated with Definitive Chemoradiation Before and After Implementation of Organized Cervical Cancer Screening in Serbia.Cancers · 2026
   Article
2. Cervical Cancer Screening in Transition: Global Challenges and Local Realities.International journal of women's health · 2026
   Review
3. Case Report: Possible spatially-distinctFrontiers in medicine · 2026
   Article
4. Determinants of cervical cancer screening among women aged 30 to 49 years in 20 low- and middle-income countries: A multilevel analysis.PloS one · 2026
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

5 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as